Trial · NCT04739345
Effect of Pentoxifylline on Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection
NCT04739345, Not applicable, Completed, Ain Shams University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Pentoxifylline on Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection. Trials, record NCT04739345. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04739345
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Pentoxifylline on Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection
- NCT number
- NCT04739345
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 69 participants, actual
- Lead sponsor
- Ain Shams University
- Conditions
- Covid19, Corona Virus Infection, Cytokine Storm
- Interventions
- Pentoxifylline
- First posted
- 2021-02-04
- Last updated
- 2023-02-09
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in patients' clinical status | Two weeks | Change in clinical status will be assessed daily using six category ordinal scale. The categories were defined as follows: 1) patient discharged, 2) hospitalization not requiring supplemental oxygen, 3) hospitalization requiring supplemental low-flow oxygen, 4) hospitalization requiring high-flow supplemental oxygen, 5) hospitalization requiring invasive mechanical ventilation, 6) death. |
| Primary | Time to increase in oxygenation | 48 hours | Time to increase in SpO2/FiO2 of 50 or greater compared to the baseline SpO2/FiO2 |
| Primary | Duration of hospitalization | Two weeks | Length of hospital stay |
| Primary | In hospital mortality | Two weeks | Death occurrence during hospitalization |
| Secondary | Incidence of non-invasive mechanical ventilation | Two weeks | Need for non-invasive mechanical ventilation |
| Secondary | Duration of non-invasive mechanical ventilation | Two weeks | Time required on non-invasive mechanical ventilation |
| Secondary | Incidence of invasive mechanical ventilation | Two weeks | Need for invasive mechanical ventilation |
| Secondary | Duration of invasive mechanical ventilation | Two weeks | Time required on invasive mechanical ventilation |
| Secondary | Occurrence of secondary infection | Two weeks | Occurrence of sepsis |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04739345
GET https://conductscience.org/api/trials/v1/NCT04739345/registered